Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Aug 7, 2026
- Incorporated
- Delaware
- Filings on record
- 417 filings
- On EDGAR
- CIK 1823239
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 23
News 8 of 55
Prospectuses and Registrations 8 of 11
- S-8 Registration statement for an employee plan May 12, 2025
- 424B4 Final prospectus for an offering Sep 13, 2021
- S-1 Registration statement for an offering Sep 7, 2021
- 424B4 Final prospectus for an offering Apr 9, 2021
- S-1/A Registration statement for an offering, amended Apr 6, 2021
- S-1 Registration statement for an offering Apr 5, 2021
- S-8 Registration statement for an employee plan Nov 23, 2020
- 424B4 Final prospectus for an offering Nov 23, 2020
Proxies 8
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 19, 2021
- PRE 14A Preliminary proxy statement Apr 9, 2021
Ownership 8 of 276
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Aug 11, 2026
- 4 Insider reported a trade Aug 3, 2026
- 4 Insider reported a trade Jul 10, 2026
- 4 Insider reported a trade Jul 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 23, 2026
- 4 Insider reported a trade Jun 10, 2026
Other 8 of 44
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 18, 2025
- NT 10-K Notice that an annual report will be late Mar 4, 2025
- UPLOAD Comment letter from SEC staff Feb 20, 2025
- CORRESP Reply to SEC staff Feb 19, 2025
- UPLOAD Comment letter from SEC staff Sep 17, 2024
- CORRESP Reply to SEC staff Aug 16, 2024
- UPLOAD Comment letter from SEC staff Jul 19, 2024
Everything here comes from Maravai Lifesciences Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.